Skip to main content

SANDOZ 618 Pill - yellow capsule/oblong, 18mm

Pill with imprint SANDOZ 618 is Yellow, Capsule/Oblong and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sandoz Pharmaceuticals Inc.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANDOZ 618

Rivastigmine tartrate 1.5 mg SANDOZ 618

Rivastigmine Tartrate

Imprint
SANDOZ 618
Strength
1.5 mg
Color
Yellow
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC)
00781-2614 (Discontinued)
Inactive Ingredients
gelatin, hypromelloses, magnesium stearate, microcrystalline cellulose, ferric oxide red, silicon dioxide, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.